Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Cash Flow Quality Index
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Cash Flow Quality Index of 2.55x as of March 2025. Operating cash flow of CN¥39.75 Million exceeds net income of CN¥15.58 Million, indicating high earnings quality where cash backs reported profits. Explore Jiangsu Aidea Pharmaceutical Co Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Quality Index (2016–2020)
Historical Cash Flow Quality Index for Jiangsu Aidea Pharmaceutical Co Ltd across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Jiangsu Aidea Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2020)
Year-by-year earnings quality comparison for Jiangsu Aidea Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Jiangsu Aidea Pharmaceutical Co Ltd market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.41x | CN¥56.17 Million | CN¥39.77 Million | ▼ -15.4% |
| 2019 | 1.67x | CN¥56.20 Million | CN¥33.65 Million | ▲ +143.0% |
| 2018 | -3.89x | CN¥-33.50 Million | CN¥8.62 Million | ▼ -276.9% |
| 2016 | 2.20x | CN¥31.29 Million | CN¥14.24 Million | — |